Podcast appearances and mentions of Steven D Pearson

In this new episode of MHE Talks: Improving Patient Access podcast, Steven D. Pearson, M.D., M.Sc., warns that high prices can squander an opportunity to bring innovative medications into clinical use. 

Madeleine (Maca) and Tanya are close friends who play for the Australian beach handball team. They both juggle full time jobs: Maca is a lawyer and Tanya a teacher. Tanya also has ulcerative colitis. In this episode, Maca and Tanya discuss the pressures of managing professional careers and health on top of being elite athletes. Experts interviewed include Debbie Beths (Tanya's mother), Dr. Steven D. Pearson (President, Institute for Clinical and Economic Review), Dr. Leonora Risse (Applied Economist, RMIT University), Ebiye Jeremy Udo-Udoma (USA Men's Beach Handball Team), and Janet McAffe (Madeleine's mother). Audio clips from YouTube's Beach Handball - China vs Australia, ANOC World Beach Games Qatar 2019, Anne-Marie Slaughter: Can we all "have it all"?, and Lean In: Women, Work and the Will to Lead.

Our hosts are joined by Steven D. Pearson, MD, MSc, the Founder and President of the Institute for Clinical and Economic Review (ICER), an independent non-profit organization that evaluates the evidence on the value of medical tests, treatments, and delivery system innovations to encourage collaborative efforts to improve patient care and control costs.

Our hosts are joined by Steven D. Pearson, MD, MSc, the Founder and President of the Institute for Clinical and Economic Review (ICER), an independent non-profit organization that evaluates the eviden

The Institute for Clinical and Economic Review’s (ICER) Midwest Comparative Effective Public Advisory Council (CEPAC) will hold is inaugural meeting on May 26, 2016 in St. Louis “to discuss the comparative clinical effectiveness and value of therapies of multiple myeloma.”  The goal is to create recommendations that health insurers (or payers) will use to determine reimbursement levels for drugs used in myeloma treatment.  Since the public announcement of ICER’s plan in February 2016, the draft reports have been strongly criticized by myeloma specialists, pharmaceutical companies, and more recently, patient advocates.  Steven Pearson will discuss ICER’s perspective, addressing critics of ICER’s methodology, process, definitions of value, and, as of now, the lack of inclusion of patient views.